Implementing a nurse-coordinated, integrated, shared-care model involving specialists and general practitioners in breast cancer post-treatment follow-up: a Phase II randomised controlled trial
- Conditions
- Breast CancerCancer - Breast
- Registration Number
- ACTRN12619001594112
- Lead Sponsor
- Professor Raymond Chan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 63
Patients who
- are treated at the Princess Alexandra Hospital
- following criteria will be considered for inclusion in the study:
- are from 4 weeks pre-completion up to 18 months after completion of adjuvant treatment for early stage breast cancer patients (including Ductal Carcinoma In-Situ (DCIS) and locally advanced) at the Princess Alexandra Hospital; OR within 4 weeks to 18 months post-surgery if they are not scheduled for any further adjuvant therapy
- have received a diagnosis of curable early breast cancer (i.e. no distant metastases);
- are able to speak and read English;
- are at least 18 years of age;
- are ambulatory patient at the time of recruitment;
- have an Eastern Cooperative Oncology Group performance status 0 or 1;
- are able to nominate a GP to be involved in their follow-up; and
- have access to a telephone.
- the presence of severe mental, cognitive or physical conditions that would limit the patient’s ability to participate.
- breast cancer recurrence
- presence of distant metastases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Health Related Quality of Life as measured by the the Functional assessment of Cancer therapy-breast (FACT-B), which consists of a general questionnaire (27-item FACT-G) and also a 15-item breast-specific subscale.[Measured at baseline, 3 months, 6 months, 12 months]
- Secondary Outcome Measures
Name Time Method